Methodological considerations in the design of trials for safety assessment of new drugs and chemical entities.

ABSTRACT:

SUBMITTER: Pater C 

PROVIDER: S-EPMC549209 | biostudies-literature | 2005 Feb

REPOSITORIES: biostudies-literature